Top-News
Biotechnologie USA

Ayala Pharmaceuticals Inc News

Aktie
WKN:  A3DMBH ISIN:  US0076244062 US-Symbol:  ADXS
0,258 €
+0,00 €
0,00%
31.05.24 21:43:01
Handeln Depot/Watchlist
Aktienanzahl *
10,75 Mio.
Marktkapitalisierung *
2,54 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 08.02.2024

Ayala Pharmaceuticals Inc News

23.12.21 - PR Newswire
OTC Markets Group Welcomes Advaxis, Inc. to OTCQX
OTC Markets Group Welcomes Advaxis, Inc. to OTCQX PR Newswire
26.08.21 - PR Newswire
Thinking about buying stock in Zomedica, Advaxis, Kaixin Auto, SelectQuote, or Coty?
Thinking about buying stock in Zomedica, Advaxis, Kaixin Auto, SelectQuote, or Coty? PR Newswire
16.07.21 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS PR Newswire
14.07.21 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates STFC, HBMD, ICBK, ADXS, FOE; Shareholders are Encouraged to Contact the Firm
INVESTIGATION ALERT: Halper Sadeh LLP Investigates STFC, HBMD, ICBK, ADXS, FOE; Shareholders are Encouraged to Contact the Firm PR Newswire
13.07.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds UFS, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds UFS, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations PR Newswire
07.07.21 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates USCR, QTS, MCF, ADXS; Shareholders are Encouraged to Contact the Firm
INVESTIGATION ALERT: Halper Sadeh LLP Investigates USCR, QTS, MCF, ADXS; Shareholders are Encouraged to Contact the Firm PR Newswire
06.07.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Advaxis, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Advaxis, Inc. PR Newswire
20.05.21 - PR Newswire
Thinking about buying stock in Advaxis, Cisco Systems, Atossa Therapeutics, Palantir Technologies, or Sundial Growers?
Thinking about buying stock in Advaxis, Cisco Systems, Atossa Therapeutics, Palantir Technologies, or Sundial Growers? PR Newswire
19.05.21 - PR Newswire
Thinking about buying stock in Advaxis, Fubotv, Sundial Growers, Riot Blockchain, or Vipshop Holdings?
Thinking about buying stock in Advaxis, Fubotv, Sundial Growers, Riot Blockchain, or Vipshop Holdings? PR Newswire
01.04.19 - PR Newswire
Thinking about buying stock in Aurora Cannabis Inc., Advaxis Inc., Caesars Entertainment Corp., Estre Ambiental Inc., or New Concept Energy Inc.?
Thinking about buying stock in Aurora Cannabis Inc., Advaxis Inc., Caesars Entertainment Corp., Estre Ambiental Inc., or New Concept Energy Inc.? PR Newswire
05.06.17 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Advaxis, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Advaxis, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
01.06.17 - PR Newswire
Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials
Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials Customized suite to support Phase 1 study of ...
27.02.17 - PR Newswire
Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy
Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-​Targeting Immunotherapy PR Newswire
28.10.16 - PR Newswire
Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro Pharmaceutical
Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro ...
27.10.16 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS PR Newswire
02.08.16 - PR Newswire
Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration Collaboration Will Advance Highly Targeted, Patient-​Specific Treatment Approach Advaxis Will Hold a ...
08.07.15 - PR Newswire
Advaxis Appoints Dr. Shelonitda S. Rose as Vice President, Clinical Development
Advaxis Appoints Dr. Shelonitda S. Rose as Vice President, Clinical Development Former Director, Oncology Clinical Research for Merck & Co. to Lead Advaxis's Growing Clinical ...
02.07.14 - PR Newswire
Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy
Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy PR Newswire
29.05.14 - PR Newswire
Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates
Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates PR Newswire
13.05.14 - PR Newswire
Aratana Therapeutics Reports First Quarter 2014 Results
Aratana Therapeutics Reports First Quarter 2014 Results --Conference Call Today, May 13, 2014, 4:45 p.m. Eastern Time-- PR Newswire

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »